Benzinga | Aug 6, 2020 08:12AM EDT

TherapeuticsMD Q2 GAAP EPS $(0.19) Misses $(0.17) Estimate, Sales $10.70M Beat $10.20M Estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is unchanged from the same period last year. The company reported quarterly sales of $10.70 million which beat the analyst consensus estimate of $10.20 million by 4.91 percent. This is a 76.03 percent increase over sales of $6.08 million the same period last year.